TEXAS INSTRUMENTS INC Debt Disclosure
| December 31, | |||||||||||
| 2025 | 2024 | ||||||||||
Notes due 2025 at 1.375% | — | 750 | |||||||||
Notes due 2026 at 1.125% | 500 | 500 | |||||||||
Notes due 2027 at 4.60% | 650 | 650 | |||||||||
Notes due 2027 at 2.90% | 500 | 500 | |||||||||
Notes due 2028 at 4.60% | 700 | 700 | |||||||||
Notes due 2029 at 4.60% | 650 | 650 | |||||||||
Notes due 2029 at 2.25% | 750 | 750 | |||||||||
Notes due 2030 at 1.75% | 750 | 750 | |||||||||
Notes due 2030 at 4.50% | 550 | — | |||||||||
Notes due 2031 at 1.90% | 500 | 500 | |||||||||
Notes due 2032 at 3.65% | 400 | 400 | |||||||||
Notes due 2033 at 4.90% | 950 | 950 | |||||||||
Notes due 2034 at 4.85% | 600 | 600 | |||||||||
Notes due 2035 at 5.10% | 650 | — | |||||||||
Notes due 2039 at 3.875% | 750 | 750 | |||||||||
Notes due 2048 at 4.15% | 1,500 | 1,500 | |||||||||
Notes due 2051 at 2.70% | 500 | 500 | |||||||||
Notes due 2052 at 4.10% | 300 | 300 | |||||||||
Notes due 2053 at 5.00% | 650 | 650 | |||||||||
Notes due 2054 at 5.15% | 750 | 750 | |||||||||
Notes due 2063 at 5.05% | 1,550 | 1,550 | |||||||||
| Total debt | 14,150 | 13,700 | |||||||||
| Net unamortized discounts, premiums and issuance costs | (102) | (104) | |||||||||
| Total debt, including net unamortized discounts, premiums and issuance costs | 14,048 | 13,596 | |||||||||
| Current portion of long-term debt | (500) | (750) | |||||||||
| Long-term debt | $ | 13,548 | $ | 12,846 | |||||||
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Feb 6, 2026 | Showing above |
| 2024 | Feb 14, 2025 | |
| 2023 | Feb 2, 2024 | |
| 2022 | Feb 3, 2023 | |
| 2021 | Feb 4, 2022 | |
| 2020 | Feb 5, 2021 | |
| 2019 | Feb 20, 2020 | |
| 2017 | Feb 22, 2018 | |
About Debt Disclosures
Debt disclosures detail a company's borrowing structure — the types of instruments, interest rates, maturity schedule, and covenant restrictions that define its financial obligations and flexibility. This section is essential for assessing refinancing risk, interest rate exposure, and the margin of safety against financial distress.
Key signals: the maturity schedule reveals concentration risk — large maturities within 1-2 years during tight credit markets can force dilutive refinancing or asset sales. Compare the fair value of debt against carrying amount to gauge whether the market views the company's credit risk differently than the balance sheet suggests. Watch covenant compliance disclosures for tightening cushions, especially leverage and interest coverage ratios. Variable-rate debt exposure quantifies sensitivity to interest rate changes. Secured versus unsecured mix affects recovery rates and future borrowing capacity. Compare net debt-to-EBITDA against industry peers and covenant limits to assess financial health.